跳至主要内容
临床试验/CTRI/2016/11/007425
CTRI/2016/11/007425尚未招募3 期

Efficacy and Safety of Bryophyllum Pinnatum (Lam.) in Patients of Renal Stone: A Prospective, Parallel group, Randomized, Open Labelled study

Department of Pharmacology0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of both the genders aged > 18 Years of age.
  • Renal stone >8 mm and <11 mm (single or multiple) visible on USG.
  • Total leucocyte count and Serum creatinine level within normal range.
  • Ability to tolerate oral fluids and Analgesic drugs.
  • Patientâ??s willingness for follow up.
  • Patient not on contraceptives or calcium therapy.
  • Patient not involved in any other clinical trial in last 30 days.
  • Patient not having Dementia or other cognitive disorders prohibiting informed consent.

排除标准

  • Children and elderly patient.
  • Pregnancy or planning for pregnancy.
  • Lactating mother.
  • History of any substance abuse.
  • Active urinary tract infection
  • Obstructive Uropathy, Benign prostatic hyperplasia or hydronephrosis.
  • Any malignancy.
  • People leaving with HIV AIDS (PLHA).
  • Hepatitis-B, Hepatitis-C.
  • Person with single Kidney.
  • Previous renal surgery.
  • Cardiac diseases, Hypertension or Patient on diuretics.
  • Metabolic disorders (Hyper thyroidism, Hyper para thyroidism)
  • Known case of Gout.

研究者

相似试验